Thank you for your interest in Tetra Biotech.

PCR is a technology with decades of history, yet the COVID-19 pandemic redefined its value and impact. As molecular diagnostics moved out of the laboratory and onto the front lines of healthcare worldwide, the world came to recognize the fundamental value of PCR’s accuracy and reliability.

Even so, research and diagnostic laboratories still contend with a different supplier for every product and mismatched performance standards — in a system where no one takes responsibility for the workflow as a whole. That is where we began asking a simple question.

What if one dedicated company could take responsibility for the entire PCR workflow? The path we have taken is our answer to that question.

Our technological foundation, TetraZyme™, was developed through Structure-Guided Mutation Engineering (SGME) to move beyond the limits of conventional enzymes. It is not a technology built for a single product — it is the foundation of every solution Tetra Biotech delivers.

“Shaping Values Together” is the direction we have chosen — a commitment to creating value alongside our partners. We look forward to sharing that journey with you.